EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma

Maiia Soloveva iD, Maksim Solovev iD, Natalya Risinskaya iD, Elena Nikulina, Igor Yakutik, Bella Biderman, Tatiana Obukhova, Yulia Chabaeva iD, Sergej Kulikov, Andrey Sudarikov iD, Larisa Mendeleeva

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maiia Soloveva und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia. Hauptthemen laut MEDLINE: Multiple Myeloma, Mutation, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a disease characterized by spatiotemporal heterogeneity of tumor clones. Different genetic aberrations can be observed simultaneously in tumor cells from different loci, and as the disease progresses, new subclones may appear. The role of liquid biopsy, which is based on the analysis of tumor DNA circulating in the blood plasma, continues to be explored in MM. Here, we present an analysis of the STR profiles and mutation status of the KRAS, NRAS, and BRAF genes, evaluated in plasma free circulating tumor DNA (ctDNA), CD138+ bone marrow cells, and plasmacytomas. The prospective single-center study included 97 patients, with a median age of 55 years. Of these, 94 had newly diagnosed symptomatic MM, and three had primary plasma cell leukemia. It should be noted that if mutations were detected only in ctDNA, “non-classical” codons were more often affected. A variety of adverse laboratory and clinical factors have been associated with the detection of rare KRAS or NRAS gene mutations in bone marrow or ctDNA, suggesting that these mutations may be factors of an unfavorable prognosis for MM. Liquid biopsy studies provide undeniable fundamental information about tumor heterogeneity and clonal evolution in MM. Moreover, we focus on using liquid biopsy to identify new high-risk factors for MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaMutationProto-Oncogene Proteins p21(ras)HumansMiddle AgedFemaleMaleAgedAdultProto-Oncogene Proteins B-rafCirculating Tumor DNAGTP PhosphohydrolasesMAP Kinase Signaling SystemMembrane ProteinsAged, 80 and overProspective StudiesLiquid Biopsy

Stichwörter der Autor:innen

BRAF genesKRASNRASSTR profilefree circulating tumor DNA in plasmaliquid biopsyloss of heterozygositymultiple myelomaplasmacytoma

Substanzen

Proto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins B-rafCirculating Tumor DNAGTP PhosphohydrolasesKRAS protein, humanNRAS protein, humanBRAF protein, humanMembrane Proteins

Autor:innen und Institutionen

  • National Medical Research Center for Hematology, Novy Zykovski Lane, 4a, 125167 Moscow, Russia.

ORCID-Profile: Maiia Soloveva, Maksim Solovev, Natalya Risinskaya, Yulia Chabaeva, Andrey Sudarikov

Zitieren

APA

Soloveva, M., Solovev, M., Risinskaya, N., Nikulina, E., Yakutik, I., Biderman, B., Obukhova, T., Chabaeva, Y., Kulikov, S., Sudarikov, A., & Mendeleeva, L. (2024). Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179426

Vancouver

Soloveva M, Solovev M, Risinskaya N, Nikulina E, Yakutik I, Biderman B, et al. Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179426

BibTeX
@article{Soloveva2024,
  author = {Soloveva, Maiia and Solovev, Maksim and Risinskaya, Natalya and Nikulina, Elena and Yakutik, Igor and Biderman, Bella and Obukhova, Tatiana and Chabaeva, Yulia and Kulikov, Sergej and Sudarikov, Andrey and Mendeleeva, Larisa},
  title = {Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179426}
}
Kostenlos starten →